US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
DK1953162T3
(da)
*
|
2001-02-24 |
2012-09-10 |
Boehringer Ingelheim Pharma |
Xanthinderivater, deres fremstilling og deres anvendelse som lægemiddel.
|
ATE395912T1
(de)
|
2001-03-27 |
2008-06-15 |
Merck & Co Inc |
Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
|
CN100341862C
(zh)
|
2001-09-14 |
2007-10-10 |
三菱制药株式会社 |
噻唑烷衍生物及其医药用途
|
DE60304911D1
(de)
|
2002-02-25 |
2006-06-08 |
Eisai Co Ltd |
Xanthin-Derivate als DPP-IV-Inhibitoren
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
AU2003247772A1
(en)
|
2002-06-27 |
2004-01-19 |
Schering Aktiengesellschaft |
Substituted quinoline ccr5 receptor antagonists
|
TW200404796A
(en)
*
|
2002-08-19 |
2004-04-01 |
Ono Pharmaceutical Co |
Nitrogen-containing compound
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
US7569574B2
(en)
|
2002-08-22 |
2009-08-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Purine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
AU2003301436A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Amgen Inc. |
Benzimidazole derivatives and their use as vanilloid receptor ligands
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
JP2005170792A
(ja)
*
|
2002-11-22 |
2005-06-30 |
Mitsubishi Pharma Corp |
L−プロリン誘導体およびその医薬としての用途。
|
US7109192B2
(en)
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
UY28103A1
(es)
*
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
WO2004069828A1
(ja)
*
|
2003-02-04 |
2004-08-19 |
Mitsubishi Pharma Corporation |
ピペリジン化合物およびその医薬用途
|
CL2004000409A1
(es)
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
US7713983B2
(en)
|
2003-03-03 |
2010-05-11 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
US7687625B2
(en)
|
2003-03-25 |
2010-03-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
JP4710606B2
(ja)
*
|
2003-04-18 |
2011-06-29 |
小野薬品工業株式会社 |
スピロピペリジン化合物およびその医薬用途
|
PL1620082T3
(pl)
|
2003-05-05 |
2010-10-29 |
Probiodrug Ag |
Medyczne zastosowanie inhibitorów cyklazy glutaminylowej i glutaminianowej do leczenia choroby Alzheimera i zespołu Downa
|
CN101837127A
(zh)
|
2003-05-05 |
2010-09-22 |
前体生物药物股份公司 |
谷氨酰胺酰基和谷氨酸环化酶效应物的应用
|
CA2524531A1
(en)
*
|
2003-05-14 |
2004-12-02 |
Merck And Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
AU2003902946A0
(en)
*
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
US7566707B2
(en)
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
BRPI0411713B8
(pt)
*
|
2003-06-20 |
2021-05-25 |
Hoffmann La Roche |
compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização
|
CA2530679A1
(en)
*
|
2003-06-30 |
2005-04-07 |
Hif Bio, Inc. |
Compounds for treating angiogenesis
|
US7169926B1
(en)
|
2003-08-13 |
2007-01-30 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EP1506967B1
(en)
*
|
2003-08-13 |
2007-11-21 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7678909B1
(en)
|
2003-08-13 |
2010-03-16 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
JP2007505121A
(ja)
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
JP5707014B2
(ja)
|
2003-10-15 |
2015-04-22 |
プロビオドルグ エージー |
グルタミニル、及びグルタミン酸シクラーゼのエフェクターの使用
|
JP2007509898A
(ja)
|
2003-11-03 |
2007-04-19 |
プロビオドルグ エージー |
神経障害治療に有用な組合せ
|
CA2545641A1
(en)
|
2003-11-17 |
2005-06-02 |
Novartis Ag |
Use of organic compounds
|
DE10355304A1
(de)
*
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
NZ547965A
(en)
*
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
LT3366283T
(lt)
|
2004-01-20 |
2021-12-10 |
Novartis Ag |
Tiesioginio presavimo formulė ir procesas
|
WO2005073186A1
(ja)
*
|
2004-01-29 |
2005-08-11 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
US7304086B2
(en)
|
2004-02-05 |
2007-12-04 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
KR101130433B1
(ko)
*
|
2004-02-05 |
2012-03-27 |
교린 세이야꾸 가부시키 가이샤 |
비시클로에스테르 유도체
|
CN1922139B
(zh)
*
|
2004-02-18 |
2010-12-29 |
杏林制药株式会社 |
双环酰胺衍生物
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
DE102004009039A1
(de)
*
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
WO2005082847A1
(ja)
*
|
2004-02-27 |
2005-09-09 |
Kyorin Pharmaceutical Co., Ltd. |
ビシクロ誘導体
|
US7348346B2
(en)
|
2004-03-08 |
2008-03-25 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
US7732446B1
(en)
|
2004-03-11 |
2010-06-08 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
US7393847B2
(en)
|
2004-03-13 |
2008-07-01 |
Boehringer Ingleheim International Gmbh |
Imidazopyridazinediones, their preparation and their use as pharmaceutical compositions
|
CN102134229B
(zh)
|
2004-03-15 |
2020-08-04 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
US7179809B2
(en)
*
|
2004-04-10 |
2007-02-20 |
Boehringer Ingelheim International Gmbh |
2-Amino-imidazo[4,5-d]pyridazin-4-ones, their preparation and their use as pharmaceutical compositions
|
US7439370B2
(en)
|
2004-05-10 |
2008-10-21 |
Boehringer Ingelheim International Gmbh |
Imidazole derivatives, their preparation and their use as intermediates for the preparation of pharmaceutical compositions and pesticides
|
RS51106B
(sr)
*
|
2004-05-12 |
2010-10-31 |
Pfizer Products Inc. |
Derivati prolina i njihova upotreba kao inhibitora dipeptidil peptidaze iv
|
CN1968949B
(zh)
*
|
2004-05-12 |
2011-05-04 |
辉瑞产品公司 |
脯氨酸衍生物和其作为二肽基肽酶iv抑制剂的用途
|
FR2870538B1
(fr)
*
|
2004-05-19 |
2006-07-14 |
Servier Lab |
Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
WO2005118555A1
(en)
*
|
2004-06-04 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
DE102004030502A1
(de)
|
2004-06-24 |
2006-01-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
|
WO2006008644A1
(en)
*
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
US7842707B2
(en)
|
2004-07-23 |
2010-11-30 |
Nuada, Llc |
Peptidase inhibitors
|
US7951816B2
(en)
|
2004-08-27 |
2011-05-31 |
Ono Pharmaceutical Co., Ltd. |
Compound containing basic group and use thereof
|
US7928107B2
(en)
|
2004-09-02 |
2011-04-19 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
DE102004043944A1
(de)
|
2004-09-11 |
2006-03-30 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(3-Amino-piperidin-1-yl)-7-(but-2-inyl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004044221A1
(de)
*
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
FR2876688B1
(fr)
*
|
2004-10-14 |
2007-03-16 |
Aventis Pharma Sa |
Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
EP1828192B1
(en)
|
2004-12-21 |
2014-12-03 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2006073167A1
(ja)
*
|
2005-01-07 |
2006-07-13 |
Ono Pharmaceutical Co., Ltd. |
ピロリジン誘導体
|
DOP2006000008A
(es)
*
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
CN102372705A
(zh)
*
|
2005-02-18 |
2012-03-14 |
田边三菱制药株式会社 |
脯氨酸衍生物的盐,其溶剂合物,及其生产方法
|
CA2598530C
(en)
*
|
2005-03-03 |
2014-12-16 |
Janssen Pharmaceutica N.V. |
Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists
|
ATE478075T1
(de)
|
2005-03-08 |
2010-09-15 |
Janssen Pharmaceutica Nv |
Diazaspiro-ä4,4ü-nonanderivate als neurokinin- (nk1)-antagonisten
|
EP1879881A2
(en)
*
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
US7553861B2
(en)
|
2005-04-22 |
2009-06-30 |
Alantos Pharmaceuticals Holding, Inc. |
Dipeptidyl peptidase-IV inhibitors
|
CA2605847C
(en)
*
|
2005-04-26 |
2014-02-04 |
Mitsubishi Tanabe Pharma Corporation |
Ddp-iv inhibitors for the treatment of postprandial hyperlipidemia
|
KR101438234B1
(ko)
*
|
2005-06-03 |
2014-09-04 |
미쓰비시 타나베 파마 코퍼레이션 |
의약의 병용 및 그 용도
|
ATE550031T1
(de)
|
2005-06-06 |
2012-04-15 |
Univ Georgetown |
Zusammensetzungen und verfahren für die lipomodellierung
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
TW200738701A
(en)
*
|
2005-07-26 |
2007-10-16 |
Du Pont |
Fungicidal carboxamides
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
JP5147401B2
(ja)
*
|
2005-09-06 |
2013-02-20 |
塩野義製薬株式会社 |
Pgd2受容体アンタゴニスト活性を有するインドールカルボン酸誘導体
|
EA015169B1
(ru)
|
2005-09-14 |
2011-06-30 |
Такеда Фармасьютикал Компани Лимитед |
Применение ингибиторов дипептидилпептидазы
|
CN102675221A
(zh)
|
2005-09-16 |
2012-09-19 |
武田药品工业株式会社 |
用于制备嘧啶二酮衍生物的方法中的中间体
|
PL1961744T3
(pl)
|
2005-11-18 |
2013-09-30 |
Ono Pharmaceutical Co |
Związek zawierający grupę zasadową oraz jego zastosowanie
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
JP5101489B2
(ja)
*
|
2006-03-08 |
2012-12-19 |
杏林製薬株式会社 |
アミノアセチルピロリジンカルボニトリル誘導体の製造方法およびその製造中間体
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
CN101410385B
(zh)
|
2006-03-28 |
2011-08-24 |
高点制药有限责任公司 |
具有组胺h3受体活性的苯并噻唑类
|
EP1971862B1
(en)
|
2006-04-11 |
2010-11-10 |
Arena Pharmaceuticals, Inc. |
Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
TW200815351A
(en)
*
|
2006-05-02 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
EP1852108A1
(en)
*
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
EP2540725A1
(de)
*
|
2006-05-04 |
2013-01-02 |
Boehringer Ingelheim International GmbH |
Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
|
US8618122B2
(en)
|
2006-05-16 |
2013-12-31 |
Ono Pharmaceutical Co., Ltd. |
Compound having acidic group which may be protected, and use thereof
|
JP5318757B2
(ja)
*
|
2006-06-16 |
2013-10-16 |
ハー・ルンドベック・アクチエゼルスカベット |
神経因性疼痛の治療のための、組み合わされたセロトニンおよびノルエピネフリン再取り込み阻害を有する4−[2−(4−メチルフェニルスルファニル)−フェニル]ピペリジンの結晶形
|
US8071583B2
(en)
*
|
2006-08-08 |
2011-12-06 |
Boehringer Ingelheim International Gmbh |
Pyrrolo[3,2-D] pyrimidines as DPP-IV inhibitors for the treatment of diabetes mellitus
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
WO2008114857A1
(ja)
*
|
2007-03-22 |
2008-09-25 |
Kyorin Pharmaceutical Co., Ltd. |
アミノアセチルピロリジンカルボニトリル誘導体の製造方法
|
KR20120030570A
(ko)
|
2007-04-03 |
2012-03-28 |
미쓰비시 타나베 파마 코퍼레이션 |
디펩티딜 펩티다아제 4 저해 화합물과 감미료와의 병용
|
CL2008003653A1
(es)
*
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
PE20140960A1
(es)
|
2008-04-03 |
2014-08-15 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
WO2009143153A1
(en)
*
|
2008-05-23 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Substituted pyrrolidine amides as modulators of the histamine h3 receptor
|
KR20190016601A
(ko)
|
2008-08-06 |
2019-02-18 |
베링거 인겔하임 인터내셔날 게엠베하 |
메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
CA2732984A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Kyorin Pharmaceutical Co., Ltd. |
Process for production of bicyclo[2.2.2]octylamine derivative
|
WO2010018866A1
(ja)
*
|
2008-08-14 |
2010-02-18 |
杏林製薬株式会社 |
安定化された医薬組成物
|
PE20110297A1
(es)
|
2008-08-15 |
2011-05-26 |
Boehringer Ingelheim Int |
Inhibidores de dpp-4 para la cicatrizacion de heridas
|
RU2011113823A
(ru)
|
2008-09-10 |
2012-10-20 |
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) |
Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
MX2011004258A
(es)
|
2008-10-22 |
2011-06-01 |
Merck Sharp & Dohme |
Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
JP2012512848A
(ja)
|
2008-12-23 |
2012-06-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
有機化合物の塩の形態
|
TW201036975A
(en)
|
2009-01-07 |
2010-10-16 |
Boehringer Ingelheim Int |
Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
|
TWI466672B
(zh)
|
2009-01-29 |
2015-01-01 |
Boehringer Ingelheim Int |
小兒科病人糖尿病之治療
|
CA2752437C
(en)
|
2009-02-13 |
2017-07-11 |
Boehringer Ingelheim International Gmbh |
Antidiabetic medications
|
RU2011142829A
(ru)
|
2009-03-27 |
2013-05-10 |
Киорин Фармасьютикал Ко., Лтд. |
Препарат матричного типа с пролонгированным высвобождением, содержащий базисную добавку
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
NZ599298A
(en)
|
2009-11-27 |
2014-11-28 |
Boehringer Ingelheim Int |
Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
|
ES2596324T3
(es)
*
|
2009-12-18 |
2017-01-05 |
Mitsubishi Tanabe Pharma Corporation |
Preparación de teneligliptina con elución estabilizada
|
EP2538784B1
(en)
|
2010-02-25 |
2015-09-09 |
Merck Sharp & Dohme Corp. |
Benzimidazole derivatives useful anti-diabetic agents
|
WO2011113947A1
(en)
|
2010-03-18 |
2011-09-22 |
Boehringer Ingelheim International Gmbh |
Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions
|
EP2556056A1
(en)
|
2010-04-06 |
2013-02-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
GB201006166D0
(en)
*
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
JP6034781B2
(ja)
|
2010-05-05 |
2016-11-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
併用療法
|
EP3725325B1
(en)
|
2010-06-24 |
2023-05-31 |
Boehringer Ingelheim International GmbH |
Diabetes therapy
|
SG188548A1
(en)
|
2010-09-22 |
2013-04-30 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
CN103619334A
(zh)
*
|
2011-01-19 |
2014-03-05 |
朱红文 |
噻唑烷衍生物和其治疗用途
|
KR20150075120A
(ko)
|
2011-02-25 |
2015-07-02 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병제로서 유용한 신규 시클릭 아자벤즈이미다졸 유도체
|
WO2012135570A1
(en)
|
2011-04-01 |
2012-10-04 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145603A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
WO2012145604A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
JP5863789B2
(ja)
*
|
2011-06-01 |
2016-02-17 |
田辺三菱製薬株式会社 |
ピラゾール誘導体の製造方法
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
DK2731947T3
(en)
|
2011-07-15 |
2019-04-23 |
Boehringer Ingelheim Int |
SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2849755A1
(en)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
|
CN103420981A
(zh)
*
|
2012-05-21 |
2013-12-04 |
中国医学科学院药物研究所 |
含有取代吡咯烷基的硫代吗啉类化合物
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
US9518048B2
(en)
|
2012-08-31 |
2016-12-13 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of teneligliptin
|
WO2014074668A1
(en)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulators of gpr119 and the treatment of disorders related thereto
|
KR20150118158A
(ko)
|
2013-02-22 |
2015-10-21 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 비시클릭 화합물
|
EP2970119B1
(en)
|
2013-03-14 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
EP2967067B1
(en)
|
2013-03-15 |
2017-11-29 |
Monsanto Technology LLC |
N-,c-disubstituted azoles for controlling nematode pests
|
CN104177295B
(zh)
*
|
2013-05-24 |
2016-08-17 |
南京华威医药科技开发有限公司 |
替格列汀关键中间体1-(3-甲基-1-苯基-5-吡唑基)哌嗪的制备方法
|
CN104211685A
(zh)
*
|
2013-05-29 |
2014-12-17 |
中国医学科学院药物研究所 |
含有取代吡咯烷基的硫代吗啉类化合物
|
CN103275010A
(zh)
*
|
2013-05-30 |
2013-09-04 |
上海皓元生物医药科技有限公司 |
一种1-(3-甲基-1-苯基-1h-吡唑-5-基)哌嗪的制备方法
|
CN104230917B
(zh)
*
|
2013-06-24 |
2017-04-05 |
南京华威医药科技开发有限公司 |
一种脯氨酸衍生物盐的水合物及其生产方法
|
WO2015019238A1
(en)
|
2013-08-06 |
2015-02-12 |
Ranbaxy Laboratories Limited |
Process for the preparation of n-protected (5s)-5-(1,3-thiazolidin-3-ylcarbonyl)pyrrolidin-3-one
|
WO2015019239A1
(en)
|
2013-08-06 |
2015-02-12 |
Ranbaxy Laboratories Limited |
Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
WO2015063709A1
(en)
|
2013-10-31 |
2015-05-07 |
Ranbaxy Laboratories Limited |
Process for the preparation of 1-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazine
|
JP6615109B2
(ja)
|
2014-02-28 |
2019-12-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Dpp−4阻害薬の医学的使用
|
CN105085358A
(zh)
*
|
2014-05-07 |
2015-11-25 |
中国医学科学院药物研究所 |
4-取代吡咯烷甲酰基硫代吗啉类dpp-iv抑制剂
|
CN105085359A
(zh)
*
|
2014-05-07 |
2015-11-25 |
中国医学科学院药物研究所 |
含氮杂环取代的吡咯烷甲酰基硫代吗啉类dpp-iv抑制剂
|
WO2015173779A1
(en)
|
2014-05-16 |
2015-11-19 |
Micro Labs Limited |
Process for the preparation of teneligliptin and its novel intermediates
|
CN105294673B
(zh)
*
|
2014-06-18 |
2018-04-13 |
四川科伦药物研究院有限公司 |
一种氢溴酸替格列汀的合成方法
|
CN104529858A
(zh)
*
|
2015-01-13 |
2015-04-22 |
佛山市赛维斯医药科技有限公司 |
含卤代金刚烷和酰胺类衍生物、其制备方法和用途
|
CN104529856A
(zh)
*
|
2015-01-13 |
2015-04-22 |
佛山市赛维斯医药科技有限公司 |
一种硝基金刚烷酰胺衍生物、其制备方法和用途
|
CN104496876A
(zh)
*
|
2015-01-13 |
2015-04-08 |
佛山市赛维斯医药科技有限公司 |
一种羟基金刚烷酰胺衍生物、其制备方法和用途
|
BR112017019170A2
(pt)
|
2015-03-09 |
2018-07-10 |
Intekrin Therapeutics, Inc. |
métodos para o tratamento de doença do fígado gorduroso não alcoólico e / ou lipodistrofia
|
WO2017096323A1
(en)
*
|
2015-12-02 |
2017-06-08 |
Astraea Therapeutics, Llc |
Piperidinyl nociceptin receptor compounds
|
US10112924B2
(en)
|
2015-12-02 |
2018-10-30 |
Astraea Therapeutics, Inc. |
Piperdinyl nociceptin receptor compounds
|
CA3022202A1
(en)
|
2016-06-10 |
2017-12-14 |
Boehringer Ingelheim International Gmbh |
Combinations of linagliptin and metformin
|
EP3551176A4
(en)
|
2016-12-06 |
2020-06-24 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC HETEROCYCLIC COMPOUNDS
|
US10968232B2
(en)
|
2016-12-20 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
WO2018162722A1
(en)
|
2017-03-09 |
2018-09-13 |
Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke |
Dpp-4 inhibitors for use in treating bone fractures
|
JP2020515639A
(ja)
|
2017-04-03 |
2020-05-28 |
コヒラス・バイオサイエンシズ・インコーポレイテッド |
進行性核上性麻痺の処置のためのPPARγアゴニスト
|
JP7450534B2
(ja)
*
|
2017-10-19 |
2024-03-15 |
帝人ファーマ株式会社 |
ベンズイミダゾール誘導体及びその用途
|
JP6985179B2
(ja)
*
|
2018-02-27 |
2021-12-22 |
田辺三菱製薬株式会社 |
プロリンアミド化合物の製造方法
|
CN108997308A
(zh)
*
|
2018-07-09 |
2018-12-14 |
西藏大学 |
一种苯并咪唑类衍生物及其制备方法和应用
|
KR102494848B1
(ko)
|
2018-10-10 |
2023-02-02 |
주식회사 파마코스텍 |
테네리글립틴 2토실산염 2수화물의 결정형 ⅰ형 및 그 제조방법
|
KR20200127480A
(ko)
|
2019-05-02 |
2020-11-11 |
연성정밀화학(주) |
테네리글립틴 에디실산염 결정형 및 이의 제조방법
|
CR20230314A
(es)
|
2020-12-17 |
2023-08-18 |
Astrazeneca Ab |
N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas
|
WO2023002011A1
(en)
*
|
2021-07-23 |
2023-01-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Gram-negative bacteria efflux pump inhibitors
|